Exhibitor Hall

The Lois Price Spratlen Foundation was founded to honor the spirit and legacy of Dr. Lois Price Spratlen. Began as a scholarship program of the Association of Advanced Practice Psychiatric Nurses, the foundation has awarded fifteen scholarships to deserving mental health graduate-level nursing students from throughout Washington State since becoming an independent nonprofit in 2016. Learn more at www.theLois.org.

Contact Pat McCowan, Acting Executive Director, at gro.s1686167002ioleh1686167002t@rot1686167002cerid1686167002evitu1686167002cexe1686167002 or 425-780-6065.

UW Psychiatry Consultation Lines

Our free provider-to-provider consultation lines help eligible providers who are seeking clinical advice regarding adult and perinatal patients with mental health and/or substance use disorders. The consultation lines provide on-demand service and are staffed by psychiatry faculty in the UW Department of Psychiatry.

Hours: Available 24/7

• Phone: (877) 927-7924
• Email: ude.w1686167002u@awl1686167002cp1686167002  

At L&I, we know healthcare providers are essential to ensuring workers recover and return to work. As Washington’s workers compensation payer, we strive to be good partners by offering providers dedicated support and resources. For more information, contact us at vog.a1686167002w.inL1686167002@kcab1686167002deefr1686167002edivo1686167002rP1686167002.

Intra-Cellular Therapies is a biopharmaceutical company founded on Paul Greengard’s Nobel Prize-winning research that uncovered how therapies affect the inner-working of cells in the body. We leverage this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. To learn more about our product from psychiatric thought leaders such as Drs Stahl, Nasrallah, Cutler, Mattingly, Kunovac, and Amber Hoberg, PMHNP, please visit: https://www.treatmentperspectives.com/scz/IntraCellular.

The GeneSight test is a pharmacogenomic test that analyzes clinically important genetic variations which may impact how your patient metabolizes and responds to certain medications used to treat mental health conditions. It has been given to more than one and a half million patients by tens of thousands of clinicians to provide genetic information that is unique to each patient. The test is a powerful tool to augment your knowledge, experience and passion for your patients. Learn more at GeneSight.com.